Literature DB >> 2379041

Diversity of antibodies to type II collagen in patients with rheumatoid arthritis: detection by binding to alpha-chains and to cyanogen bromide peptides.

C Buckee1, K Morgan, S Ayad, I Collins, R B Clague, P J Holt.   

Abstract

Antibodies to denatured type II collagen were detected in the sera of a group of patients with rheumatoid arthritis by ELISA and by immunoblotting. The antibodies were further examined by immunoblotting against cyanogen-bromide derived peptides of type II collagen. The majority of sera reacted against only one or two peptides and antibodies to the CB-10 and CB-11 peptides were those most commonly found. However, some sera reacted with up to eight peptides, indicating that patients had antibodies to differing combinations of epitopes on type II collagen. Examination of sequential serum samples from an individual patient showed that there were changes in the class of antibody produced to type II collagen and that antibodies to different peptides were preferentially produced at different times in the course of the disease. Thus there was a selective response to different peptides of type II collagen not only between patients but also at different times in the course of disease in the same patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379041     DOI: 10.1093/rheumatology/29.4.254

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

1.  Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.

Authors:  S Turner; N P Bakker; B A t Hart; P J Holt; K Morgan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

2.  High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.

Authors:  Mohammed Mullazehi; Linda Mathsson; Jon Lampa; Johan Rönnelid
Journal:  Ann Rheum Dis       Date:  2006-10-13       Impact factor: 19.103

3.  Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M J Rowley; I R Mackay; C A Brand; J F Bateman; D Chan
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Anti-collagen antibodies in systemic sclerosis and in primary Raynaud's phenomenon.

Authors:  L Riente; B Marchini; M P Dolcher; A Puccetti; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

5.  Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis.

Authors:  Andrew D Cook; Robyn Gray; John Ramshaw; Ian R Mackay; Merrill J Rowley
Journal:  Arthritis Res Ther       Date:  2004-08-11       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.